Breast Cancer Clinical Trial

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Summary

To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).

View Full Description

Full Description

This study is currently available in Canada only.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Post-menopausal women 18 years of age or above with proven diagnosis of advanced adenocarcinoma of the breast (locoregionally recurrent or metastatic disease)
ER-positive and/or PR-positive tumor based on local laboratory results
HER2-negative tumor based on local laboratory results
Patients must be appropriate candidates for letrozole therapy (Canada: first-line patients only)

Exclusion Criteria:

Patients who have previously participated in a palbociclib trial or who have received prior treatment with any CDK inhibitor

Study is for people with:

Breast Cancer

Study ID:

NCT02142868

Recruitment Status:

No longer available

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 50 Locations for this study

See Locations Near You

CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center
Bakersfield California, 93309, United States
MedStar Georgetown University Hospital
Washington District of Columbia, 20007, United States
Washington Cancer Institute at MedStar Washington Hospital Center
Washington District of Columbia, 20010, United States
Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care
Duluth Georgia, 30096, United States
Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care
Lawrenceville Georgia, 30046, United States
Presence Saint Joseph Hospital
Chicago Illinois, 60657, United States
North Shore Oncology-Hematology Associates, Ltd.
Crystal Lake Illinois, 60014, United States
North Shore Oncology-Hematology Associates, Ltd.
Libertyville Illinois, 60048, United States
Presence Medical Group Hematology Oncology
Northbrook Illinois, 60062, United States
Illinois CancerCare, P.C.
Peoria Illinois, 61615, United States
Presence Infusion Care - Skokie
Skokie Illinois, 60077, United States
Metairie Oncologist, LLC
Metairie Louisiana, 70006, United States
SKCCC at Johns Hopkins, The Harry and Jeannette Weinberg Building
Baltimore Maryland, 21287, United States
SKCCC at Johns Hopkins, Green Spring Station
Lutherville Maryland, 21093, United States
The West Clinic, P.C.
Corinth Mississippi, 38834, United States
Jackson Oncology Associates, PLLC
Jackson Mississippi, 39202, United States
Mississippi Baptist Health Systems
Jackson Mississippi, 39202, United States
Jackson Oncology Associates, PLLC
Jackson Mississippi, 39216, United States
The West Clinic, P.C. d/b/a West Cancer Center
Southaven Mississippi, 38671, United States
ProHealthCARE Associates, LLP
Lake Success New York, 11042, United States
Northwest Cancer Specialists dba Compass Oncology
Portland Oregon, 97213, United States
Northwest Cancer Specialists dba Compass Oncology
Portland Oregon, 97225, United States
UPMC Cancer Center Beaver
Beaver Pennsylvania, 15009, United States
UPMC Cancer Center Arnold Palmer at Mountainview
Greensburg Pennsylvania, 15601, United States
UPMC Cancer Center Greenville
Greenville Pennsylvania, 16125, United States
UPMC Cancer Center Monroeville
Monroeville Pennsylvania, 15146, United States
Magee-Womens Hospital of UPMC
Pittsburgh Pennsylvania, 15213, United States
UPMC Cancer Center St. Margarets
Pittsburgh Pennsylvania, 15215, United States
University of Pittsburgh Cancer Institute, Investigational Drug Service, William M. Cooper Pavilion
Pittsburgh Pennsylvania, 15232, United States
University of Pittsburgh Medical Center, William M. Cooper Pavilion, Hillman Cancer Center
Pittsburgh Pennsylvania, 15232, United States
UPMC Cancer Center Passavant (HOA)
Pittsburgh Pennsylvania, 15237, United States
UPMC Cancer Center Passavant (OHA)
Pittsburgh Pennsylvania, 15237, United States
UPMC Cancer Center Northwest
Seneca Pennsylvania, 16346, United States
Mount Nittany Medical Center
State College Pennsylvania, 16803, United States
The West Clinic, P.C. d/b/a West Cancer Center
Germantown Tennessee, 38138, United States
The West Clinic, P.C. d/b/a West Cancer Center
Memphis Tennessee, 38104, United States
The West Clinic, P.C. d/b/a West Cancer Center
Memphis Tennessee, 38120, United States
Texas Oncology -Baylor Charles A. Sammons Cancer Center
Dallas Texas, 75246, United States
Texas Oncology - Memorial City
Houston Texas, 77024, United States
Medical Oncology & Hematology Associates of Northern Virginia, Ltd.
Fairfax Virginia, 22031, United States
Medical Oncology & Hematology Associates of Northern Virginia, Ltd.
Reston Virginia, 20190, United States
Swedish Cancer Institute
Seattle Washington, 98104, United States
Northwest Cancer Specialists dba Compass Oncology
Vancouver Washington, 98683, United States
Northwest Cancer Specialists dba Compass Oncology
Vancouver Washington, 98684, United States
Tom Baker Cancer Centre
Calgary Alberta, T2N 4, Canada
Holy Cross Centre
Calgary Alberta, T2S 3, Canada
Cross Cancer Institute
Edmonton Alberta, T6G 1, Canada
Queen Elizabeth II (QEII) Health Sciences Centre, Nova Scotia Cancer Centre
Halifax Nova Scotia, B3H 1, Canada
London Regional Cancer Program
London Ontario, N6A 4, Canada
The Ottawa Hospital Cancer Centre
Ottawa Ontario, K1H 8, Canada
Sunnybrook health Sciences Centre
Toronto Ontario, M4N 3, Canada
Sunnybrook Odette Cancer Centre
Toronto Ontario, M4N 3, Canada
SunnyBrook Research Institute
Toronto Ontario, M4N 3, Canada
McGill University Health Centre (MUHC), Glen Site, Royal Victoria Hospital, Cedars Cancer Centre
Montreal Quebec, H4A 3, Canada
CHU de Quebec - Hospital du Saint-Sacrement
Quebec , G1S 4, Canada

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Study ID:

NCT02142868

Recruitment Status:

No longer available

Sponsor:


Pfizer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider